These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11195611)

  • 21. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
    Guo H; Lee JD; Ueda T; Cheng J; Shan J; Wang J
    Indian J Med Res; 2004 Jan; 119(1):33-7. PubMed ID: 14997992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine, folate, and cardiovascular disease.
    Ward M
    Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ; Solà I; Lathyris D; Dayer M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006612. PubMed ID: 28816346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 27. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
    Bostom AG; Gohh RY; Liaugaudas G; Beaulieu AJ; Han H; Jacques PF; Dworkin L; Rosenberg IH; Selhub J
    Atherosclerosis; 1999 Jul; 145(1):221-4. PubMed ID: 10428313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine, folates, and the eye.
    Wright AD; Martin N; Dodson PM
    Eye (Lond); 2008 Aug; 22(8):989-93. PubMed ID: 18064053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
    Liaugaudas G; Jacques PF; Selhub J; Rosenberg IH; Bostom AG
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):849-51. PubMed ID: 11348885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
    Ho GY; Eikelboom JW; Hankey GJ; Wong CR; Tan SL; Chan JB; Chen CP
    Stroke; 2006 Feb; 37(2):456-60. PubMed ID: 16397167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease.
    Dierkes J; Bissé E; Nauck M; Orth M; Mayer H; Luley C; Wieland H
    Clin Chem Lab Med; 1998 Jun; 36(7):453-7. PubMed ID: 9746269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary strategies for lowering homocysteine concentrations.
    Riddell LJ; Chisholm A; Williams S; Mann JI
    Am J Clin Nutr; 2000 Jun; 71(6):1448-54. PubMed ID: 10837284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
    Rogers JD; Sanchez-Saffon A; Frol AB; Diaz-Arrastia R
    Arch Neurol; 2003 Jan; 60(1):59-64. PubMed ID: 12533089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins.
    Haynes WG
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):391-9. PubMed ID: 12652108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.